Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Fecal micr...
Saved in:
Published in | Molecular medicine (Cambridge, Mass.) Vol. 25; no. 1; pp. 35 - 16 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
01.08.2019
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved.
Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR).
The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes.
SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice. |
---|---|
AbstractList | Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Methods Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients’ colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). Results The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. Conclusions SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved.OBJECTIVESSystemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved.Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR).METHODSFecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR).The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes.RESULTSThe fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes.SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice.CONCLUSIONSSLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients' colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice. Abstract Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose of this study is to identify the influence of gut microbiota in the pathogenesis of SLE, and to investigate the mechanism involved. Methods Fecal microbiota from C57/BL6 mice and SLE prone mice were examined using next-generation sequencing (NGS). Germ free mice were given fecal microbiota transplantation (FMT), and their gut microbiome and gene expression in recipients’ colons were examined by NGS. The anti-double stranded DNA (anti-dsDNA) antibodies in recipients were determined using an enzyme-linked immunosorbent assay (ELISA). The immune cell profiles of mice were analyzed by flow cytometry at the 3rd week after FMT, and the expression of genes associated with SLE after FMT was determined using quantitative real-time PCR (qRT-PCR). Results The fecal microbiota of SLE mice had lower community richness and diversity than healthy mice. Fecal microbiota of recipient mice were similar to their donors. Fecal microbiome from SLE mice could lead to a significant increase of anti-dsDNA antibodies and promote the immune response in recipient mice. Our results also indicated that fecal microbiome from SLE mice resulted in significant changes in the distribution of immune cells and upregulated expression of certain lupus susceptibility genes. Conclusions SLE is associated with alterations of gut microbiota. Fecal microbiome from SLE mice can induce the production of anti-dsDNA antibodies in germ free mice and stimulate the inflammatory response, and alter the expression of SLE susceptibility genes in these mice. |
ArticleNumber | 35 |
Author | Xu, Xiaoxue Li, Mengtao Niu, Haitao Ma, Yiyangzi Cai, Jun Wei, Qiang |
Author_xml | – sequence: 1 givenname: Yiyangzi surname: Ma fullname: Ma, Yiyangzi – sequence: 2 givenname: Xiaoxue surname: Xu fullname: Xu, Xiaoxue – sequence: 3 givenname: Mengtao surname: Li fullname: Li, Mengtao – sequence: 4 givenname: Jun surname: Cai fullname: Cai, Jun – sequence: 5 givenname: Qiang surname: Wei fullname: Wei, Qiang – sequence: 6 givenname: Haitao orcidid: 0000-0003-2210-2051 surname: Niu fullname: Niu, Haitao |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31370803$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk1r3DAQhkVJaT7aH9BLMfTSi1N9S74USmjTQKCX9iy00nhXi225klzYfx85m5QmkIOQmHnn0TDznqOTKU6A0HuCLwnR8nMmGFPcYtLVg2krXqEzIqhumRT6pL6xki0Rgpyi85z3VUwEF2_QKSNMYY3ZGfLXS2nG4FLchFhsM6c4xgJN2UETpn6w42hLTIcmQZ7jlNfofXK2ZRe3MEEOuYl9kw-5QAU1wzIvuYF0qKq1Ni_5LXrd2yHDu4f7Av3-_u3X1Y_29uf1zdXX29ZJRkurJXOK9JR52xHKKagNF5I71uPO9Qy8Esp2QjvPBGBPuaW4A69tTyQTGLMLdHPk-mj3Zk5htOlgog3mPhDT1thUghvAWI_rRz2xfCO4c2wDynNS2ZgqDtpX1pcja142I3gHU0l2eAJ9mpnCzmzjXyOlqtPXFfDpAZDinwVyMWPIDobBThCXbCiVmmEtOlqlH59J93FJUx2VoYJLjQVTq-rD_x39a-VxmVWgjoK6zZwT9MaFYkuIa4NhMASb1TbmaBtTbWNW2xhRK8mzykf4yzV3gw7GKA |
CitedBy_id | crossref_primary_10_1177_09612033231155840 crossref_primary_10_3389_fimmu_2020_606936 crossref_primary_10_3389_fimmu_2021_667097 crossref_primary_10_1016_j_heliyon_2024_e37432 crossref_primary_10_1016_j_isci_2023_107122 crossref_primary_10_3389_fimmu_2021_727485 crossref_primary_10_1038_s41522_021_00215_6 crossref_primary_10_3390_ijerph182312836 crossref_primary_10_1016_j_jaut_2023_103109 crossref_primary_10_1186_s12967_020_02539_x crossref_primary_10_1007_s11926_023_01115_8 crossref_primary_10_3389_fmicb_2020_00628 crossref_primary_10_3389_fmicb_2024_1319654 crossref_primary_10_1093_cei_uxac057 crossref_primary_10_3390_antiox11010084 crossref_primary_10_1039_D1FO00560J crossref_primary_10_3389_fimmu_2021_796865 crossref_primary_10_3390_ijms24065748 crossref_primary_10_1016_j_clim_2021_108892 crossref_primary_10_3389_fimmu_2023_1202850 crossref_primary_10_1016_j_autrev_2024_103607 crossref_primary_10_1016_j_clim_2022_109109 crossref_primary_10_1016_j_exppara_2024_108863 crossref_primary_10_3390_antiox10091426 crossref_primary_10_1126_scitranslmed_aax2220 crossref_primary_10_7759_cureus_57512 crossref_primary_10_56082_annalsarscibio_2024_2_84 crossref_primary_10_1016_j_molmed_2020_04_001 crossref_primary_10_1007_s11926_023_01102_z crossref_primary_10_1016_j_coi_2019_08_007 crossref_primary_10_1111_imr_12847 crossref_primary_10_1136_rmdopen_2020_001324 crossref_primary_10_3390_biomedicines12030616 crossref_primary_10_3390_microorganisms13030556 crossref_primary_10_1080_19490976_2023_2247053 crossref_primary_10_3389_fimmu_2020_00282 crossref_primary_10_1080_08916934_2024_2378876 crossref_primary_10_1002_JLB_1MR0321_660R crossref_primary_10_3390_cells10040785 crossref_primary_10_1007_s11926_021_00986_z crossref_primary_10_3389_fimmu_2022_1050895 crossref_primary_10_3748_wjg_v28_i18_1875 crossref_primary_10_2174_1381612826666201211114609 crossref_primary_10_3389_fimmu_2022_883747 crossref_primary_10_3390_jpm11070625 crossref_primary_10_3389_fimmu_2023_1228754 crossref_primary_10_2478_rir_2023_0027 crossref_primary_10_1038_s41584_023_01071_8 crossref_primary_10_3389_fphys_2022_1070569 crossref_primary_10_1136_annrheumdis_2021_220687 crossref_primary_10_3390_microorganisms9061132 crossref_primary_10_1002_advs_202201581 crossref_primary_10_1177_09612033231156075 crossref_primary_10_3390_ijms25115608 crossref_primary_10_37349_emed_2022_00112 crossref_primary_10_1007_s11684_022_0957_7 crossref_primary_10_1016_j_micres_2024_127613 crossref_primary_10_3389_fphys_2021_715506 crossref_primary_10_3389_fimmu_2022_897971 crossref_primary_10_1007_s40588_023_00213_6 crossref_primary_10_1016_j_mam_2025_101349 crossref_primary_10_1136_lupus_2022_000776 crossref_primary_10_1016_j_tjnut_2024_01_015 crossref_primary_10_3389_fimmu_2020_01703 crossref_primary_10_3390_biomedicines11123142 crossref_primary_10_3389_fimmu_2024_1365554 crossref_primary_10_1016_j_blre_2024_101252 crossref_primary_10_1177_09612033211025095 crossref_primary_10_1016_j_intimp_2023_109946 crossref_primary_10_1038_s41598_024_77672_4 crossref_primary_10_1186_s12865_024_00632_0 crossref_primary_10_3389_fimmu_2021_615859 crossref_primary_10_3389_fimmu_2020_01741 crossref_primary_10_1080_19490976_2021_1916278 crossref_primary_10_3389_fimmu_2021_686501 crossref_primary_10_3389_fimmu_2023_1120958 crossref_primary_10_1016_j_jchromb_2021_123096 crossref_primary_10_1007_s11894_024_00932_w crossref_primary_10_1097_BOR_0000000000000993 crossref_primary_10_1111_bph_15512 crossref_primary_10_3389_fimmu_2021_651191 crossref_primary_10_1016_j_autrev_2021_102765 crossref_primary_10_3389_fmicb_2024_1477187 crossref_primary_10_3389_fimmu_2022_954764 |
Cites_doi | 10.1016/j.gpb.2015.09.004 10.1136/gut.2005.073817 10.1146/annurev.immunol.20.100301.064833 10.1038/nmeth.2604 10.1097/BOR.0b013e3283535801 10.1186/s40168-018-0603-4 10.1016/S0163-7258(99)00022-4 10.1128/AEM.02288-17 10.1038/nri2707 10.1111/j.1365-2249.2010.04139.x 10.1042/CS20160415 10.1126/scitranslmed.aan2306 10.1016/j.it.2004.09.005 10.1186/gb-2011-12-6-r60 10.1126/science.1246980 10.1146/annurev.immunol.26.021607.090400 10.1038/nri1572 10.1016/j.cyto.2012.03.003 10.1038/ng.2439 10.3389/fimmu.2015.00610 10.1016/j.clim.2014.12.013 10.1038/ng.3434 10.4049/jimmunol.178.8.4937 10.1084/jem.20090900 10.1016/j.immuni.2014.04.004 10.1136/annrheumdis-2018-214856 10.1038/nprot.2007.315 10.1016/j.tim.2004.01.001 10.3389/fimmu.2018.02307 10.1073/pnas.97.12.6670 10.1016/j.cell.2006.02.017 10.1002/art.40827 10.1007/s11926-017-0695-z 10.1186/s13075-015-0755-6 10.1007/s12016-017-8605-8 10.1016/j.jim.2018.05.014 10.1016/j.chom.2008.09.009 10.1016/j.autrev.2016.07.012 10.4049/jimmunol.1002795 10.1038/s41598-017-14223-0 10.4049/jimmunol.169.5.2694 10.1007/BF02737642 10.4049/jimmunol.173.5.3119 10.1002/ame2.12065 10.1126/science.1104816 10.3892/etm.2014.1578 10.1128/mBio.01548-14 10.1186/s40168-017-0300-8 10.1186/1471-2105-15-14 10.1093/ibd/izy177 10.1056/NEJMra071297 10.1128/AEM.02676-14 10.1186/s40168-019-0683-9 10.1002/eji.200838417 10.1084/jem.20081712 10.4049/jimmunol.162.11.6322 10.1016/j.molcel.2015.05.004 10.1182/blood-2012-05-433755 |
ContentType | Journal Article |
Copyright | 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. The Author(s) 2019 |
Copyright_xml | – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. – notice: The Author(s) 2019 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s10020-019-0102-5 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1528-3658 |
EndPage | 16 |
ExternalDocumentID | oai_doaj_org_article_ad0f23f1a4b54cc3be7d4158c0274e8d PMC6676588 31370803 10_1186_s10020_019_0102_5 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: ; grantid: 2016-I2M-1-006 – fundername: ; grantid: 2017YFA0105204 |
GroupedDBID | --- -ET 0R~ 123 29M 2WC 36B 5RE 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ACGFO ACMJI ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE IAO IH2 IHR ISR ITC KQ8 OK1 OVT P2P PHGZM PHGZT PIMPY RBZ RNS ROL RPM RSV SDH SJN SOJ SV3 TR2 UKHRP WOQ ACRMQ C24 M~E NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c632t-863c71f23da91242e7b4564c3f09cf3ed757a958cd35e0d24a209ed8af1635003 |
IEDL.DBID | DOA |
ISSN | 1076-1551 1528-3658 |
IngestDate | Wed Aug 27 01:29:04 EDT 2025 Thu Aug 21 13:38:34 EDT 2025 Fri Jul 11 09:50:27 EDT 2025 Mon Jun 30 19:23:33 EDT 2025 Thu Jan 02 23:00:09 EST 2025 Thu Apr 24 22:59:44 EDT 2025 Tue Jul 01 01:25:20 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Fecal microbiota transplantation2 Immune response4 Gut microbiota1 Lupus susceptibility gene5 Systemic lupus erythematosus3 |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c632t-863c71f23da91242e7b4564c3f09cf3ed757a958cd35e0d24a209ed8af1635003 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2210-2051 |
OpenAccessLink | https://doaj.org/article/ad0f23f1a4b54cc3be7d4158c0274e8d |
PMID | 31370803 |
PQID | 2546805372 |
PQPubID | 5066171 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ad0f23f1a4b54cc3be7d4158c0274e8d pubmedcentral_primary_oai_pubmedcentral_nih_gov_6676588 proquest_miscellaneous_2268308592 proquest_journals_2546805372 pubmed_primary_31370803 crossref_citationtrail_10_1186_s10020_019_0102_5 crossref_primary_10_1186_s10020_019_0102_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-08-01 |
PublicationDateYYYYMMDD | 2019-08-01 |
PublicationDate_xml | – month: 08 year: 2019 text: 2019-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York – name: London |
PublicationTitle | Molecular medicine (Cambridge, Mass.) |
PublicationTitleAlternate | Mol Med |
PublicationYear | 2019 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | Y Ma (102_CR26) 2015; 13 S Makita (102_CR27) 2007; 178 F Backhed (102_CR3) 2005; 307 H Liu (102_CR24) 2019; 7 H Okada (102_CR41) 2010; 160 S Xiao (102_CR58) 2014; 40 A Hevia (102_CR17) 2014; 5 H Niu (102_CR40) 2008; 38 M Munoz (102_CR38) 2009; 206 T Tamura (102_CR53) 2008; 26 E Mummert (102_CR37) 2018; 459 N Rother (102_CR45) 2015; 6 J Bentham (102_CR6) 2015; 47 H Zhang (102_CR61) 2014; 80 H Bassolas-Molina (102_CR5) 2018; 9 LV Hooper (102_CR18) 2004; 12 E. H. Pieter Dijkhuizen (102_CR55) 2019; 71 M Weidenbusch (102_CR56) 2017; 131 MK Crow (102_CR10) 2014; 192 JD Forbes (102_CR15) 2018; 6 Q Mu (102_CR35) 2017; 7 XX Yu (102_CR60) 2014; 7 RE Ley (102_CR23) 2006; 124 RJ Ball (102_CR4) 2015; 17 C Mohan (102_CR32) 1998; 101 II Ivanov (102_CR19) 2008; 4 D Dembele (102_CR12) 2014; 15 S Makita (102_CR28) 2004; 173 N Segata (102_CR46) 2011; 12 RA Sinico (102_CR51) 2002; 15 C Manichanh (102_CR30) 2006; 55 MT Abreu (102_CR1) 2010; 10 Q Mu (102_CR36) 2017; 5 M Shapiro-Shelef (102_CR48) 2005; 5 B Weigmann (102_CR57) 2007; 2 A Picascia (102_CR42) 2015; 157 KK Unni (102_CR54) 1975; 2 L Morel (102_CR34) 2000; 97 MA Maldonado (102_CR29) 1999; 162 A De Groof (102_CR11) 2017; 53 N Manjarrez-Orduno (102_CR31) 2012; 44 WD Xu (102_CR59) 2012; 58 102_CR25 MA Kleinschek (102_CR21) 2009; 206 JA James (102_CR20) 2012; 24 Y Deng (102_CR13) 2017; 19 NB Blatt (102_CR8) 1999; 83 ES Sobel (102_CR52) 2002; 169 A Rahman (102_CR43) 2008; 358 D Azzouz (102_CR2) 2019; 78 A Montalban-Arques (102_CR33) 2018; 24 O Shamriz (102_CR47) 2016; 15 Teri M. Greiling (102_CR16) 2018; 10 P Brandtzaeg (102_CR9) 2004; 25 JA Reuter (102_CR44) 2015; 58 R Berland (102_CR7) 2002; 20 MN Lee (102_CR22) 2014; 343 GQ Shen (102_CR49) 1998; 16 H Niu (102_CR39) 2013; 121 Na Shi (102_CR50) 2019; 2 RC Edgar (102_CR14) 2013; 10 |
References_xml | – volume: 13 start-page: 242 issue: 4 year: 2015 ident: 102_CR26 publication-title: Genomics Proteomics Bioinformatics doi: 10.1016/j.gpb.2015.09.004 – volume: 55 start-page: 205 issue: 2 year: 2006 ident: 102_CR30 publication-title: Gut. doi: 10.1136/gut.2005.073817 – volume: 20 start-page: 253 year: 2002 ident: 102_CR7 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.20.100301.064833 – volume: 10 start-page: 996 issue: 10 year: 2013 ident: 102_CR14 publication-title: Nat Methods doi: 10.1038/nmeth.2604 – volume: 24 start-page: 383 issue: 4 year: 2012 ident: 102_CR20 publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e3283535801 – volume: 6 start-page: 221 issue: 1 year: 2018 ident: 102_CR15 publication-title: Microbiome. doi: 10.1186/s40168-018-0603-4 – volume: 101 start-page: 1362 issue: 6 year: 1998 ident: 102_CR32 publication-title: J Clin Invest – volume: 83 start-page: 125 issue: 2 year: 1999 ident: 102_CR8 publication-title: Pharmacol Ther doi: 10.1016/S0163-7258(99)00022-4 – ident: 102_CR25 doi: 10.1128/AEM.02288-17 – volume: 10 start-page: 131 issue: 2 year: 2010 ident: 102_CR1 publication-title: Nat Rev Immunol doi: 10.1038/nri2707 – volume: 160 start-page: 1 issue: 1 year: 2010 ident: 102_CR41 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2010.04139.x – volume: 131 start-page: 625 issue: 8 year: 2017 ident: 102_CR56 publication-title: Clin Sci (Lond) doi: 10.1042/CS20160415 – volume: 10 start-page: eaan2306 issue: 434 year: 2018 ident: 102_CR16 publication-title: Science Translational Medicine doi: 10.1126/scitranslmed.aan2306 – volume: 25 start-page: 570 issue: 11 year: 2004 ident: 102_CR9 publication-title: Trends Immunol doi: 10.1016/j.it.2004.09.005 – volume: 12 start-page: R60 issue: 6 year: 2011 ident: 102_CR46 publication-title: Genome Biol doi: 10.1186/gb-2011-12-6-r60 – volume: 343 start-page: 1246980 issue: 6175 year: 2014 ident: 102_CR22 publication-title: Science. doi: 10.1126/science.1246980 – volume: 26 start-page: 535 year: 2008 ident: 102_CR53 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.26.021607.090400 – volume: 5 start-page: 230 issue: 3 year: 2005 ident: 102_CR48 publication-title: Nat Rev Immunol. doi: 10.1038/nri1572 – volume: 58 start-page: 317 issue: 3 year: 2012 ident: 102_CR59 publication-title: Cytokine. doi: 10.1016/j.cyto.2012.03.003 – volume: 44 start-page: 1227 issue: 11 year: 2012 ident: 102_CR31 publication-title: Nat Genet doi: 10.1038/ng.2439 – volume: 6 start-page: 610 year: 2015 ident: 102_CR45 publication-title: Front Immunol doi: 10.3389/fimmu.2015.00610 – volume: 157 start-page: 1 issue: 1 year: 2015 ident: 102_CR42 publication-title: Clin Immunol doi: 10.1016/j.clim.2014.12.013 – volume: 47 start-page: 1457 issue: 12 year: 2015 ident: 102_CR6 publication-title: Nat Genet doi: 10.1038/ng.3434 – volume: 178 start-page: 4937 issue: 8 year: 2007 ident: 102_CR27 publication-title: J Immunol doi: 10.4049/jimmunol.178.8.4937 – volume: 206 start-page: 3047 issue: 13 year: 2009 ident: 102_CR38 publication-title: J Exp Med doi: 10.1084/jem.20090900 – volume: 40 start-page: 477 issue: 4 year: 2014 ident: 102_CR58 publication-title: Immunity. doi: 10.1016/j.immuni.2014.04.004 – volume: 78 start-page: 947 issue: 7 year: 2019 ident: 102_CR2 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2018-214856 – volume: 2 start-page: 2307 issue: 10 year: 2007 ident: 102_CR57 publication-title: Nat Protoc doi: 10.1038/nprot.2007.315 – volume: 12 start-page: 129 issue: 3 year: 2004 ident: 102_CR18 publication-title: Trends Microbiol doi: 10.1016/j.tim.2004.01.001 – volume: 9 start-page: 2307 year: 2018 ident: 102_CR5 publication-title: Front Immunol doi: 10.3389/fimmu.2018.02307 – volume: 97 start-page: 6670 issue: 12 year: 2000 ident: 102_CR34 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.97.12.6670 – volume: 124 start-page: 837 issue: 4 year: 2006 ident: 102_CR23 publication-title: Cell. doi: 10.1016/j.cell.2006.02.017 – volume: 2 start-page: 36 issue: 1 year: 1975 ident: 102_CR54 publication-title: J Rheumatol – volume: 71 start-page: 1000 issue: 6 year: 2019 ident: 102_CR55 publication-title: Arthritis & Rheumatology doi: 10.1002/art.40827 – volume: 19 start-page: 68 issue: 11 year: 2017 ident: 102_CR13 publication-title: Curr Rheumatol Rep doi: 10.1007/s11926-017-0695-z – volume: 17 start-page: 274 year: 2015 ident: 102_CR4 publication-title: Arthritis Res Ther doi: 10.1186/s13075-015-0755-6 – volume: 53 start-page: 181 issue: 2 year: 2017 ident: 102_CR11 publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-017-8605-8 – volume: 459 start-page: 11 year: 2018 ident: 102_CR37 publication-title: J Immunol Methods doi: 10.1016/j.jim.2018.05.014 – volume: 4 start-page: 337 issue: 4 year: 2008 ident: 102_CR19 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2008.09.009 – volume: 15 start-page: 859 issue: 9 year: 2016 ident: 102_CR47 publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2016.07.012 – volume: 192 start-page: 5459 issue: 12 year: 2014 ident: 102_CR10 publication-title: J Immunol doi: 10.4049/jimmunol.1002795 – volume: 7 start-page: 13675 issue: 1 year: 2017 ident: 102_CR35 publication-title: Sci Rep doi: 10.1038/s41598-017-14223-0 – volume: 169 start-page: 2694 issue: 5 year: 2002 ident: 102_CR52 publication-title: J Immunol doi: 10.4049/jimmunol.169.5.2694 – volume: 16 start-page: 321 issue: 3 year: 1998 ident: 102_CR49 publication-title: Clin Rev Allergy Immunol doi: 10.1007/BF02737642 – volume: 173 start-page: 3119 issue: 5 year: 2004 ident: 102_CR28 publication-title: J Immunol doi: 10.4049/jimmunol.173.5.3119 – volume: 2 start-page: 98 issue: 2 year: 2019 ident: 102_CR50 publication-title: Animal Models and Experimental Medicine doi: 10.1002/ame2.12065 – volume: 307 start-page: 1915 issue: 5717 year: 2005 ident: 102_CR3 publication-title: Science. doi: 10.1126/science.1104816 – volume: 7 start-page: 1135 issue: 5 year: 2014 ident: 102_CR60 publication-title: Exp Ther Med doi: 10.3892/etm.2014.1578 – volume: 5 start-page: e01548 issue: 5 year: 2014 ident: 102_CR17 publication-title: MBio. doi: 10.1128/mBio.01548-14 – volume: 5 start-page: 73 issue: 1 year: 2017 ident: 102_CR36 publication-title: Microbiome. doi: 10.1186/s40168-017-0300-8 – volume: 15 start-page: 14 year: 2014 ident: 102_CR12 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-15-14 – volume: 24 start-page: 1649 issue: 8 year: 2018 ident: 102_CR33 publication-title: Inflamm Bowel Dis doi: 10.1093/ibd/izy177 – volume: 358 start-page: 929 issue: 9 year: 2008 ident: 102_CR43 publication-title: N Engl J Med doi: 10.1056/NEJMra071297 – volume: 15 start-page: S20 issue: Suppl 6 year: 2002 ident: 102_CR51 publication-title: J Nephrol – volume: 80 start-page: 7551 issue: 24 year: 2014 ident: 102_CR61 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.02676-14 – volume: 7 start-page: 68 issue: 1 year: 2019 ident: 102_CR24 publication-title: Microbiome. doi: 10.1186/s40168-019-0683-9 – volume: 38 start-page: 3028 issue: 11 year: 2008 ident: 102_CR40 publication-title: Eur J Immunol doi: 10.1002/eji.200838417 – volume: 206 start-page: 525 issue: 3 year: 2009 ident: 102_CR21 publication-title: J Exp Med doi: 10.1084/jem.20081712 – volume: 162 start-page: 6322 issue: 11 year: 1999 ident: 102_CR29 publication-title: J Immunol doi: 10.4049/jimmunol.162.11.6322 – volume: 58 start-page: 586 issue: 4 year: 2015 ident: 102_CR44 publication-title: Mol Cell doi: 10.1016/j.molcel.2015.05.004 – volume: 121 start-page: 1986 issue: 11 year: 2013 ident: 102_CR39 publication-title: Blood. doi: 10.1182/blood-2012-05-433755 |
SSID | ssj0021545 |
Score | 2.5444303 |
Snippet | Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors. The purpose... Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental factors.... Abstract Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease whose onset and progression are affected by genetic and environmental... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 35 |
SubjectTerms | Antibodies Discriminant analysis Disease Fecal microbiota transplantation2 Feces Gene expression Genomes Gut microbiota Gut microbiota1 Hypotheses Immune response Immune response4 Immune system Laboratory animals Lupus Lupus susceptibility gene5 Medical research Microbiota Pathogenesis Software Systemic lupus erythematosus3 Taxonomy |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9UwEA-6IngRv62uEsGTEGyb5qMnUXFdBD258G4hzcf6YLd9vraH_e-dSfre-kT2mqSQTmYyv2QmvyHkbRtliNZyBmC0Y02nIuyDjWfgfbwA_6d9Chd8_yFPz5pvK7FaLtzGJa1ytyemjdoPDu_I3yNvu0bykfrD5jfDqlEYXV1KaNwmd5C6DFO61Or6wIXwIOccSobQYIlqVlri0zk8OJX4hAd8LBMHfinR9_8Pc_6bOvmXLzp5QO4vIJJ-zKv-kNwK_SNyN5eVvHpM_Nd5opfrTLE0WbpJKXeBAtajoFCgA5cptk63OUEWW1MnliceznH3W490iDTTPK8dvZg380jD9ipzvA7jPD4hZydffn4-ZUs1BeYkryemJXeqijX3tgWnXgfVIZWM47FsXeTBK6EsyNB5LkLp68bWZRu8thEgmwDjf0qO-qEPzwlVrWqdtEFyaxsnBGAepywglS5UsnShIOVOlsYtVONY8eLCpCOHliaL34D4DYrfiIK823-yyTwbNw3-hAu0H4gU2alh2J6bxeKM9SX8bKxs04nGOd4F5QGtaIcH8aB9QY53y2sWux3NtZYV5M2-GywOwyi2D8MMY2qpOfLCwZhnWRv2M-EVV4DBeUHUgZ4cTPWwp1__SqzemGwstH5x87Reknt1UlpMQTwmR9N2Dq8AFk3d66T7fwB5mAuF priority: 102 providerName: ProQuest |
Title | Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31370803 https://www.proquest.com/docview/2546805372 https://www.proquest.com/docview/2268308592 https://pubmed.ncbi.nlm.nih.gov/PMC6676588 https://doaj.org/article/ad0f23f1a4b54cc3be7d4158c0274e8d |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZtSqGX0vQVp-miQk8FU9uyHj5mSx4EGkpoYOlFyJLcLiT2srYP-fedkbxLtpT2kosP1hjk0UjzDTP6hpCPVSN8YwxLAYzWaVnLBs7B0qXgfRwH_6dcSBd8vRTn1-XFgi_utfrCmrBIDxwV99m4rClYk5uy5qW1rPbSgdNRFuMprxyevuDzNsHUFGohMIjVhiJFUDDlM3Ml8NIchkwZXt4B75ryHY8UiPv_hjb_LJq854VOX5DnE3ykx3Ha--SRb1-Sp7Gh5N0r4s7Ggd4uI7nSYOgqFNt5CiiPginB6t-GrDpdx9JYfBsGsTFx9xPPvWVPu4ZGguelpTfjauypX99FdteuH_vX5Pr05PuX83Tqo5BawYohVYJZmYMWnanAnRde1kgiY1mTVbZh3kkuTQUqdYz7zBWlAY16p0wDYI3Dtn9D9tqu9QeEykpWVhgvmDGl5RzQjpUGMErtc5FZn5Bso0ttJ5Jx7HVxo0OwoYSO6tegfo3q1zwhn7afrCLDxr-E57hAW0Ekxw4vwGT0ZDL6fyaTkKPN8uppx_Ya-wIoJLcpEvJhOwx7DRMopvXdCDKFUAwZ4UDmbbSG7UxYziSgb5YQuWMnO1PdHWmXvwKfN5YZc6UOH-Lf3pFnRTBtLFE8InvDevTvATYN9Yw8lgs5I0_mJ5ffrmZhv8Dzav7jN56AGFA |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwQviG8KA4wEL0gRaRx_5AEhBhsd2yqENmlvxrGdrdLWdE0j1H-Kv5G7OAkUob3tNXYj53zn-13v_DtCXmeF8IUxLAIwmkdpLgs4B1MXgfdxHPyfck264HAixsfp1xN-skF-dXdhsKyyOxObg9qVFv8jf4e87QrJR5IP88sIu0ZhdrVroRHUYt-vfkLIVr3f-wz7-yZJdneOPo2jtqtAZAVLlpESzMpRkTBnMnBuiZc5UqpYVsSZLZh3kkuTcWUd4z52SWqSOPNOmQKgCwcjgPfeIJspg1BmQDa3dybfvvchHgKSUOUoIgQjbR51pARe1sNQLcZLQ-DVI77mCZuGAf9Duf8Wa_7l_XbvkjstbKUfg57dIxt-dp_cDI0sVw-I-1Iv6cU0kDotDZ03RX6eArqkoMKgdRdNNp8uQkkuPm0GsSFyeYrn7bSiZUEDsfTU0vN6XlfUL1aBVbas6uohOb4WST8ig1k5808IlZnMrDBeMGNSyzmgLCsNYKPcj0Rs_ZDEnSy1bcnNscfGuW6CHCV0EL8G8WsUv-ZD8rb_yTwwe1w1eRs3qJ-IpNzNg3Jxqlsb18bF8LHFyKQ5T61luZcO8JGyGPp75YZkq9te3Z4Ulf6j10Pyqh8GG8fEjZn5soY5iVAMmehgzuOgDf1K2IhJQP1sSOSanqwtdX1kNj1reMSxvJkr9fTqZb0kt8ZHhwf6YG-y_4zcThoFxgLILTJYLmr_HEDZMn_RWgIlP67b-H4Db5pIxg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2ggJHgghQ1ieNHDggBZWkpVByotDfj2E5Zqd0sm43Q_jV-HTN2dssi1FuvsbPyjufxOTP-hpAXVSN8YwxLAYzWaVnLBvxg6VKIPo5D_FMupAu-HIn94_LTmI-3yO_VXRgsq1z5xOCoXWvxG_ku8rYrJB8pdpuhLOLr3ujN7GeKHaQw07pqpxFV5NAvf8HxrXt9sAd7_bIoRh--vd9Phw4DqRWsWKRKMCvzpmDOVBDoCi9rpFexrMkq2zDvJJem4so6xn3mitIUWeWdMg3AGA4GAb97hVyVjOdoY3J8fthDaBLrHUWKsGTIqOZK4LU9PLRleH0I4nvKN2JiaB3wP7z7b9nmX3FwdIvcHAAsfRs17jbZ8tM75Fpsabm8S9zHfkHPJpHeaWHoLJT7eQo4k4Iyg_6dhbw-ncfiXHwaBrE1cnuCnnfS0bahkWJ6YulpP-s76ufLyC_bdn13jxxfipzvk-1pO_UPCZWVrKwwXjBjSss54C0rDaCk2ucisz4h2UqW2g4059ht41SH444SOopfg_g1il_zhLxavzKLHB8XTX6HG7SeiPTc4UE7P9GDtWvjMvizTW7KmpfWstpLB0hJWfwI4JVLyM5qe_XgMzp9ruEJeb4eBmvHFI6Z-raHOYVQDDnpYM6DqA3rlbCcScD_LCFyQ082lro5Mp38CIziWOjMlXp08bKeketgcvrzwdHhY3KjCPqLlZA7ZHsx7_0TQGeL-mkwA0q-X7bd_QEjzkuW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+microbiota+promote+the+inflammatory+response+in+the+pathogenesis+of+systemic+lupus+erythematosus&rft.jtitle=Molecular+medicine+%28Cambridge%2C+Mass.%29&rft.au=Yiyangzi+Ma&rft.au=Xiaoxue+Xu&rft.au=Mengtao+Li&rft.au=Jun+Cai&rft.date=2019-08-01&rft.pub=BMC&rft.issn=1076-1551&rft.eissn=1528-3658&rft.volume=25&rft.issue=1&rft.spage=1&rft.epage=16&rft_id=info:doi/10.1186%2Fs10020-019-0102-5&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ad0f23f1a4b54cc3be7d4158c0274e8d |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1076-1551&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1076-1551&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1076-1551&client=summon |